| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.0B | $2.7B | $2.7B | $2.3B | $2.1B | $0.5B | $0.5B | $0.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.1B | $0.4B | $0.6B | $-0.1B | $0.4B | $0.5B | $0.6B | $0.1B |
| EPS (Basic) | $9.35 | $3.34 | $5.16 | $-1.24 | $3.58 | $0.94 | $1.43 | $1.29 |
| EPS (Diluted) | $9.29 | $3.33 | $5.14 | $-1.24 | $3.57 | $0.94 | $1.42 | $1.24 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $32.9B | $32.3B | $30.5B | $28.4B | $27.0B | $25.2B | $21.7B | $18.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.5B | $0.5B | $0.5B | $0.8B | $1.1B | $1.7B | $0.3B | $0.3B |
| Total Liabilities | $24.4B | $24.7B | $23.3B | $21.8B | $20.0B | $19.1B | $16.1B | $13.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $8.5B | $7.5B | $7.2B | $6.6B | $7.0B | $6.1B | $5.6B | $4.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.7B | $1.7B | $1.7B | $1.4B | $1.4B | $1.1B | $1.4B | $1.3B |
| Investing Cash Flow | $-1.3B | $-3.0B | $-2.8B | $-3.4B | $-3.1B | $-2.5B | $-3.8B | $-3.4B |
| Capital Expenditures | $0.2B | $0.4B | $0.3B | $0.2B | $0.2B | $0.2B | $0.3B | $0.3B |
| Financing Cash Flow | $-0.4B | $1.4B | $0.7B | $1.7B | $1.1B | $2.9B | $2.5B | $2.1B |